Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis Viruses”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05602870
What this trial is testing

Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit

Who this might be right for
Psychiatric DisorderPsychiatric HospitalizationAdvanced Chronic Liver Disease+1 more
University Hospital, Montpellier 180
Post-approval studies (Phase 4)Study completedNCT02202473
What this trial is testing

Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects

Who this might be right for
Chronic Hepatitis B
Southeast University, China 192
Large-scale testing (Phase 3)Study completedNCT01962441
What this trial is testing

SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 601
Not applicableStudy completedNCT01782794
What this trial is testing

Acceptability of Hepatitis B Vaccination in General Population

Who this might be right for
Hepatitis B
GlaxoSmithKline 2,413
Large-scale testing (Phase 3)Study completedNCT02216422
What this trial is testing

Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 36
Early research (Phase 1)Study completedNCT01637922
What this trial is testing

Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone

Who this might be right for
Hepatitis C
Boehringer Ingelheim 34
Not applicableStudy completedNCT03627546
What this trial is testing

HCV Seek, Test and Rapid Treatment for Young PWID

Who this might be right for
Hepatitis CDrug Use
Weill Medical College of Cornell University 39
Not applicableUnknownNCT01944527
What this trial is testing

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Who this might be right for
HCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents
ANRS, Emerging Infectious Diseases 699
Not applicableEnded earlyNCT05184283
What this trial is testing

Utilization of MAsS in Patients Undergoing LT for HCC

Who this might be right for
NAFLDHepatocellular CarcinomaLiver Diseases+3 more
Columbia University 11
Large-scale testing (Phase 3)Study completedNCT00404651
What this trial is testing

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,189
Large-scale testing (Phase 3)Study completedNCT00469131
What this trial is testing

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

Who this might be right for
Hepatitis CLiver Cirrhosis
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79
Not applicableStudy completedNCT04029454
What this trial is testing

Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule

Who this might be right for
Hepatitis B
Institut Pasteur 10,000
Large-scale testing (Phase 3)Study completedNCT00040027
What this trial is testing

Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Who this might be right for
Hepatitis CHepatitis C, Chronic
SciClone Pharmaceuticals 500
Testing effectiveness (Phase 2)UnknownNCT05382351
What this trial is testing

Antiviral Therapy for Patients With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis B Virus Infection
Sun Yat-sen University 238
Early research (Phase 1)Looking for participantsNCT07557251
What this trial is testing

Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma

Who this might be right for
Advanced HBV-Related Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 21
Post-approval studies (Phase 4)UnknownNCT01683786
What this trial is testing

36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8

Who this might be right for
Hepatitis C Infection
Chang Gung Memorial Hospital 60
Post-approval studies (Phase 4)WithdrawnNCT02135666
What this trial is testing

Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline
Early research (Phase 1)Study completedNCT01817985
What this trial is testing

Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 33
Early research (Phase 1)Study completedNCT00389376
What this trial is testing

Phase I Trial of Silymarin for Chronic Liver Diseases

Who this might be right for
Hepatitis CNon-Alcoholic Fatty Liver Disease
National Center for Complementary and Integrative Health (NCCIH) 56
Large-scale testing (Phase 3)Study completedNCT01513850
What this trial is testing

A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients

Who this might be right for
Hepatitis B
SK Chemicals Co., Ltd. 87
Next Page